Thymostimulin in advanced hepatocellular carcinoma: A phase II trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thymostimulin in advanced hepatocellular carcinoma: A phase II trial

Published:2008-03-13 Issue:1 Volume:8 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Dollinger Matthias M,Behrens Christa M,Lesske Joachim,Behl Susanne,Behrmann Curd,Fleig Wolfgang E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/1471-2407-8-72/fulltext.html

Reference31 articles.

1. Bosch FX, Ribes J, Díaz M, Cléries R: Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004, 127: S5-S16. 10.1053/j.gastro.2004.09.011.

2. Bruix J, Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002, 35: 519-524. 10.1053/jhep.2002.32089.

3. Fleig WE, Lesske J: Hepatocellular carcinoma: Primary and secondary prophylaxis as well as medical therapy. Chir Gastroenterol. 2003, 19: 247-252. 10.1159/000074010.

4. Beaugrand M, N'kontchou G, Seror O, Ganne N, Trinchet J-C: Local/regional and systemic treatments of hepatocellular carcinoma. Semin Liver Dis. 2005, 25: 201-211. 10.1055/s-2005-871199.

5. Geissler M, Mohr L, Ali MY, Grimm CF, Ritter M, Blum HE: Immunobiology and gene-based immunotherapy of hepatocellular carcinoma. Z Gastroenterol. 2003, 41: 1101-1110. 10.1055/s-2003-44304.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action;Oncology Reviews;2014-05-28

2. Translational medicine in hepatocellular carcinoma;Frontiers of Medicine;2012-05-09

3. Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields;British Journal of Cancer;2011-08

4. Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial;BMC Cancer;2010-08-24

5. Thymus und andere Immunstimulanzien;Der Onkologe;2009-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3